Dr. Joshua Marks Greenhoe, MD

Dr. Greenhoe practices at University of Virginia Medical Center - HOPD (590 Peter Jefferson Pkwy 175) in Charlottesville, Virginia.

Dr. Greenhoe's NPI, 1780640680, was assigned on April 21, 2006. Dr. Greenhoe graduated from University of Rochester School of Medicine and Dentistry in 1996. Dr. Greenhoe holds Virginia license 0101059245.

Dr. Greenhoe's primary practice is University of Virginia Medical Center - HOPD (590 Peter Jefferson Pkwy 175), at 590 Peter Jefferson Pkwy 175, Charlottesville, VA 22911.

Dr. Greenhoe's primary practice is University of Virginia Medical Center - HOPD (590 Peter Jefferson Pkwy 175) in Charlottesville, Virginia. Dr. Greenhoe is also affiliated with University Medical Center. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Greenhoe to 3 more hospitals, 4 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Greenhoe's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greenhoe practices, 11 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Greenhoe's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Greenhoe is licensed in Virginia.

CMS data shows 4,852 Medicare services from Dr. Greenhoe across 18 procedure codes in 2024, for 770 Medicare patients. Medicare paid $288,480 for them. Every service was in an office.

CMS counts 770 Medicare patients who saw Dr. Greenhoe in 2024. The largest group is 75 to 84, with 330 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Greenhoe's median patient age at 70, with 43% women.

In 2024, Dr. Greenhoe wrote 13,199 Medicare Part D claims for 1,046 patients. 90% of them were for generic drugs. CMS names the drug for 12,338 of them, across 153 drugs with 11 or more claims each, at $831,152 in total drug cost. In 2023, CMS named 10,749 claims across 139 drugs.

Dr. Greenhoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Greenhoe as offering telehealth.

CMS Open Payments shows 110 general payments to Dr. Greenhoe from 17 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $292.

Dr. Greenhoe graduated from University of Rochester School of Medicine and Dentistry in 1996.